Cita APA

López Márquez, A., Morín, M., Fernández-Peñalver, S., Badosa, C., Hernández-Delgado, A., Natera-de Benito, D., . . . Jiménez-Mallebrera, C. (2022). CRISPR/Cas9-mediated allele-specific disruption of a dominant COL6A1 pathogenic variant improves collagen VI network in patient fibroblasts.

Citación estilo Chicago

López Márquez, Arístides, et al. CRISPR/Cas9-mediated Allele-specific Disruption of a Dominant COL6A1 Pathogenic Variant Improves Collagen VI Network in Patient Fibroblasts. 2022.

Cita MLA

López Márquez, Arístides, et al. CRISPR/Cas9-mediated Allele-specific Disruption of a Dominant COL6A1 Pathogenic Variant Improves Collagen VI Network in Patient Fibroblasts. 2022.